cervical cancer - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health services.

UN-led ‘Big Catch-up’ to immunize kids after COVID-19 rampage

Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health.

by HealthQuill
April 25, 2023
0 Comments

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.

Drugs Pharma

Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.